Stocks News

LAST PRICE
297.1499
TODAY'S CHANGE (%)
Trending Up2.6199 (0.8895%)

Bid / Lots
296.5500/ 6
Ask / Lots
297.3200/ 6
Open / Previous Close
293.5500 / 294.5300
Day Range
Low 293.5001
High 297.3235
52 Week Range
Low 260.6800
High 346.8500
Volume
127,022
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- RBC Cuts Price Target on Amgen to $360 From $362, Maintains Outperform Rating, from 2 hours ago by MT Newswires
  2 hours ago by MT Newswires
  Companies Mentioned: AMGN
  07:01 AM EST, 11/25/2024 (MT Newswires) -- Amgen (AMGN) has an average rating of overweight and mean price target of $334.25, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and ...
Nov 22, 2024
- DJ The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones
  9:30PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: LLY, NVO, AMGN
  
  By Jacob Sonenshine
  
  Stocks of anti-obesity drugmakers Eli Lilly, Novo Nordisk, and Amgen have gotten hit as the market frets over what a Robert F. Kennedy Jr.-run Department of Health and Human Services would mean for the group. The worries are overblown, and investors should use the selloff to scoop the stocks up on the cheap.
Nov 21, 2024
- DJ Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barrons.com, from 2:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  2:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: LLY, NVO, AMGN
  
  By Jacob Sonenshine
  
  Stocks of anti-obesity drugmakers Eli Lilly, Novo Nordisk, and Amgen have gotten hit as the market frets over what a Robert F. Kennedy Jr.-run Department of Health and Human Services would mean for the group. The worries are overblown, and investors should use the selloff to scoop the stocks up on the cheap.
Nov 20, 2024
- DJ Amgen Names Howard Chang as Chief Scientific Officer, from 4:23PM ET on Wednesday Nov 20, 2024 by Dow Jones
  4:23PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: AMGN
  
  By Stephen Nakrosis
  
  Amgen on Wednesday said Howard Chang will join the company as senior vice president of research, effective Dec. 16.
  
  The company said Chang, who will also serve as chief scientific officer, will establish and lead research priorities within its rare disease, oncology, inflammation and cardiometabolic therapeutic areas.
- AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT, from 4:00PM ET on Wednesday Nov 20, 2024 by PR Newswire
  4:00PM ET on Wednesday Nov 20, 2024 by PR Newswire
  Companies Mentioned: AMGN
  Howard Chang, M.D., Ph.D., Joins as Senior Vice President of Research and Chief Scientific Officer
  Amgen (NASDAQ:AMGN) today announcedthat Howard Chang, M.D., Ph.D., will join the company as senior vice president of Research, effective Dec. 16, 2024. Chang will also assume the title and responsibility of serving as Amgen's chief scientific officer, reporting to Jay Bradner, M.D., executive vice president of Research and Development.

Today
- AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 2 hours ago by Accesswire
  2 hours ago by Accesswire
  Companies Mentioned: AZN
- AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: AZN
- Astrazeneca Potential Metastatic Prostate Cancer Study Shows Early Promise, from 2 hours ago by MT Newswires
  2 hours ago by MT Newswires
  Companies Mentioned: AZN
- TRUQAP(R) (capivasertib) combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: AZN
- Bernstein Adjusts Price Target on Bristol-Myers Squibb to $62 From $56, Keeps Market Perform Rating, from 3 hours ago by MT Newswires
  3 hours ago by MT Newswires
  Companies Mentioned: BMY
- DJ Sanofi's U.S. Hospital Drug-Discount Program Seems Positive But Rollout Hurdles Remain -- Market Talk, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: SNY
Nov 22, 2024
- DJ Pension Doubles Its Palantir Stake and Buys Up Intel and CVS. -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones
  9:30PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: INTC, PLTR, BMY, CVS
- DJ Sanofi Plans to Change Hospital Drug-Discount Program -- 3rd Update, from 5:20PM ET on Friday Nov 22, 2024 by Dow Jones
  5:20PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: SNY
- UBS Raises Price Target on Gilead Sciences to $96 From $70, Maintains Neutral Rating, from 2:48PM ET on Friday Nov 22, 2024 by MT Newswires
  2:48PM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: GILD
- Market Chatter: Sanofi Plans Drug Discount Policy Restriction, from 12:27PM ET on Friday Nov 22, 2024 by MT Newswires
  12:27PM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: SNY

Amgen Inc
NASDAQ:AMGNUnited States

Search Criteria

Today

RBC Cuts Price Target on Amgen to $360 From $362, Maintains Outperform Rating, from 2 hours ago by MT Newswires

Nov 22, 2024

DJ The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones

Nov 21, 2024

DJ Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barrons.com, from 2:00AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

DJ Amgen Names Howard Chang as Chief Scientific Officer, from 4:23PM ET on Wednesday Nov 20, 2024 by Dow Jones

AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT, from 4:00PM ET on Wednesday Nov 20, 2024 by PR Newswire

Peers Headlines

Today

AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 2 hours ago by Accesswire

AstraZeneca PLC (AZN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates, from 2 hours ago by Dow Jones

Astrazeneca Potential Metastatic Prostate Cancer Study Shows Early Promise, from 2 hours ago by MT Newswires

TRUQAP(R) (capivasertib) combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial, from 3 hours ago by Dow Jones

Bernstein Adjusts Price Target on Bristol-Myers Squibb to $62 From $56, Keeps Market Perform Rating, from 3 hours ago by MT Newswires

DJ Sanofi's U.S. Hospital Drug-Discount Program Seems Positive But Rollout Hurdles Remain -- Market Talk, from 5 hours ago by Dow Jones

Nov 22, 2024

DJ Pension Doubles Its Palantir Stake and Buys Up Intel and CVS. -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones

DJ Sanofi Plans to Change Hospital Drug-Discount Program -- 3rd Update, from 5:20PM ET on Friday Nov 22, 2024 by Dow Jones

UBS Raises Price Target on Gilead Sciences to $96 From $70, Maintains Neutral Rating, from 2:48PM ET on Friday Nov 22, 2024 by MT Newswires

Market Chatter: Sanofi Plans Drug Discount Policy Restriction, from 12:27PM ET on Friday Nov 22, 2024 by MT Newswires